TG THERAPEUTICS, INC. Litigation

Mar 1, 2019

Voluntary Dismissal

The plaintiff in this action has chosen not to proceed with the case. Once a case is voluntary dismissed, the courts will usually close the case and no further action will be taken.

Dec 28, 2018

Appointment of Lead Plaintiff

The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.

Oct 4, 2018

First Filed Complaint

A securities fraud class action complaint has been filed on behalf of certain investors in TG THERAPEUTICS, INC..

Feb 24, 2023

No Appeal- Closed

Jan 25, 2023

Motion to Dismiss Granted

The court has granted the defendants' request to dismiss the lawsuit. Depending on the court's decision, the plaintiffs may be allowed to file an updated complaint or pursue an appeal.

Nov 17, 2022

Motion to Dismiss

After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.

Oct 28, 2022

First Amended Complaint

A new complaint has been filed on behalf of certain investors in TG THERAPEUTICS, INC.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.

Oct 14, 2022

Scheduling Order